Mounjaro approved for blood glucose control in type 2 diabetes
A pioneering study discovers an underlying cause for infantile spasms and points to a novel therapy
20 May 2022It’s ‘Kids to parks day’: get out, get active
21 May 2022Mounjaro approved for blood glucose control in type 2 diabetes
Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.
